Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS060380 in Non-alcoholic Steatohepatitis (NASH)
NCT07198386Phase 2Active, not recruiting
- Sponsor
- Cascade Pharmaceuticals
- Start
- Sep 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thybetaxor in Nonalcoholic steatohepatitis (NASH), sponsored by Cascade Pharmaceuticals. Started Sep 2025; status: active, not recruiting.
02
Drugs
thybetaxor
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT07198386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07198386.